In combination with azacitidine or decitabine, or minimal-dose cytarabine in recently diagnosed AML aged ≥ seventy five several years or with co-morbidities that preclude the usage of intense induction chemotherapy Immune checkpoint inhibitors. An essential Section of the immune program is its power to keep itself from attacking other ordinary https://directivepublications.org/journal-of-leukemia-research/